Purkersdorf, Austria

Erik Patzelt


Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Punkersdorf, AT (1999)
  • Purkersdorf, AT (2005 - 2008)

Company Filing History:


Years Active: 1999-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Erik Patzelt

Introduction

Erik Patzelt is a notable inventor based in Purkersdorf, Austria. He has made significant contributions to the field of oncology through his innovative work in antibody development. With a total of 4 patents, Patzelt has focused on creating solutions that address critical medical challenges.

Latest Patents

One of his latest patents is titled "Antibodies specific for CD44v6." This invention pertains to antibodies with a specified sequence that are specific for an epitope coded by the variant exon v6 of the CD44 gene. It also includes nucleic acid molecules encoding these antibody proteins and methods for producing them. Furthermore, this invention provides pharmaceutical compositions that comprise these antibody proteins and their use in manufacturing a medicament for cancer treatment. Another significant patent is "Cytotoxic CD44 antibody immunoconjugates," which relates to novel conjugates of CD44 antibodies with cytotoxic compounds. This invention includes pharmaceutical compositions comprising such compounds and their application in tumor therapy.

Career Highlights

Erik Patzelt has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

Throughout his career, Patzelt has collaborated with esteemed colleagues such as Marlies Sproll and Karl-Heinz Heider. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Erik Patzelt's contributions to the field of oncology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…